Efficacy analysis between ultrasound and cytology criteria in the differentiation of malignant and benign thyroid nodules: TIRADS versus BETHESDA
Abstract
Keywords
References
- de Siqueira RA, Rodrigues A, Miamae LM, Tomimori EK, Silveira EA. Thyroid nodules in severely obese patients: frequency and risk of malignancy on ultrasonography. Endocr Res 2020; 45: 9-16.
- Daniels KE, Xu J, Liu JB, et al. Diagnostic value of TI-RADS classification system and next generation genetic sequencing in indeterminate thyroid nodules. Acad Radiol 2021; 28: 1685-91.
- Gungor K, Dokuzeylul Gungor N. Antithyroid antibodies may predict serum beta HCG levels and biochemical pregnancy losses in euthyroid women with IVF single embryo transfer. Gynecol Endocrinol 2021; 37: 702-5.
- Zhu Y, Sang Q, Jia S, Wang Y, Deyer T. Deep neural networks could differentiate Bethesda class III versus class IV/V/VI. Ann Transl Med 2019; 7: 231.
- Bian J, Wang R, Lin M. Ultrasonic S-Detect mode for the evaluation of thyroid nodules: A meta-analysis. Medicine (Baltimore) 2022; 101: e29991.
- Staibano P, Forner D, Noel CW, et al. Ultrasonography and fine-needle aspiration in indeterminate thyroid nodules: a systematic review of diagnostic test accuracy. Laryngoscope 2022; 132: 242-51.
- Ferrarazzo G, Camponovo C, Deandrea M, Piccardo A, Scappaticcio L, Trimboli P. Suboptimal accuracy of ultrasound and ultrasound-based risk stratification systems in detecting medullary thyroid carcinoma should not be overlooked. Findings from a systematic review with meta-analysis. Clin Endocrinol (Oxf) 2022; 97: 532-40.
- Nie W, Zhu L, Yan P, Sun J. Thyroid nodule ultrasound accuracy in predicting thyroid malignancy based on TIRADS system. Adv Clin Exp Med 2022; 31: 597-606.
Details
Primary Language
English
Subjects
Health Care Administration
Journal Section
Research Article
Publication Date
March 27, 2023
Submission Date
January 4, 2023
Acceptance Date
February 13, 2023
Published in Issue
Year 2023 Volume: 6 Number: 2











